Valeritas, Inc. is a medical technology company focused on providing innovative delivery solutions for insulin management in adults with Type 2 diabetes. The company’s flagship product, V-Go®, is a wearable, mechanical insulin delivery device designed to provide continuous basal insulin and on-demand bolus dosing throughout the day. Engineered as a simple, discreet patch-like device, V-Go aims to improve adherence to prescribed regimens by reducing the complexity and stigma associated with traditional insulin injections.
Established in 1996 under the name Calibra Medical Corporation, the company rebranded to Valeritas in 2013 as it refined its focus on diabetes care. V-Go received U.S. Food and Drug Administration (FDA) approval in 2012 and has since been adopted by healthcare providers seeking alternatives to multiple daily injection therapy. Valeritas conducts ongoing clinical and real-world studies to demonstrate V-Go’s impact on glycemic control, patient satisfaction, and overall treatment costs.
While Valeritas primarily serves the United States market, it has explored strategic partnerships to expand its reach into Canada and select international territories. The company supports a network of distribution and reimbursement specialists who work with physicians, diabetes educators, and payers to facilitate patient access. Training programs and digital resources complement its offerings, helping both patients and healthcare professionals optimize device use and adherence.
Under the leadership of Chief Executive Officer Andrew Whitty, Valeritas continues to focus on enhancing its commercial infrastructure and exploring potential pipeline opportunities. The management team comprises seasoned professionals with backgrounds in medical devices, diabetes care, and biopharmaceutical commercialization. By concentrating on user-centric design and clinical evidence, Valeritas aims to strengthen its position in the diabetes management landscape and contribute to better health outcomes for people living with Type 2 diabetes.
AI Generated. May Contain Errors.
Free VLRXQ Stock Alerts